LENZ Therapeutics, Inc. (LENZ) Misses Q4 EPS by 46c
Tweet
Share
E-mailGet Alerts LENZ Hot Sheet
Join SI Premium – FREE
LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q4 EPS of ($0.46).
For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Resumes Global Net Lease (GNL), Upgrades to Outperform
- Bang Mai Fang files for 5M share IPO at $5-$6/sh
- Paramount Global (PARA) Tops Q2 EPS by 175c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
